US 12264158
Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
granted A61PA61P1/16A61P19/02
Quick answer
US patent 12264158 (Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death) held by HEPAREGENIX GMBH expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- HEPAREGENIX GMBH
- Grant date
- Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P1/16, A61P19/02, A61P25/00